indazoles has been researched along with pd 184352 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grimm, J; Haydn, JM; Hufnagel, A; Maurus, K; Meierjohann, S; Schartl, M | 1 |
| Casey, PJ; Tang, J; Wang, M | 1 |
2 other study(ies) available for indazoles and pd 184352
| Article | Year |
|---|---|
The MAPK pathway as an apoptosis enhancer in melanoma.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Butadienes; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Melanoma; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation, Missense; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sulfonamides | 2014 |
Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair.
Topics: Animals; Apoptosis; Benzamides; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA Repair; Female; Genetic Vectors; HEK293 Cells; Humans; Indazoles; MAP Kinase Signaling System; Mice; Mice, SCID; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Protein Methyltransferases; Ribonucleosides; RNA, Small Interfering; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |